(Q37142019)

18 August 2017

1 reference

title

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes (English)

1 reference

18 August 2017

3

Antona J Wagstaff

1 reference

18 August 2017

4

Lesley J Scott

1 reference

18 August 2017

Stephanie K A Blick

1

1 reference

18 August 2017

Jennifer S Orman

series ordinal

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

American journal of cardiovascular drugs

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

113-125

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256588

18 August 2017

exact match

0 references

cites work

Inhibition of Factor Xa : a potential target for the development of new anticoagulants

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Evidence-based medical therapy of patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Early management of ST elevation myocardial infarction: a review of practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Determination of the anti-factor Xa activity of the synthetic pentasaccharide SR 90107A/ORG 31540 and of two structural analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Reperfusion strategies in the emergency treatment of ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

The pharmacokinetics of fondaparinux sodium in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256588

21 January 2018

Identifiers

DOI

10.1007/BF03256588

1 reference

18 August 2017

1 reference